Brucke Financial Inc. Acquires 149 Shares of UnitedHealth Group Incorporated $UNH

Brucke Financial Inc. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.2% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,280 shares of the healthcare conglomerate’s stock after buying an additional 149 shares during the period. Brucke Financial Inc.’s holdings in UnitedHealth Group were worth $399,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Nuveen LLC acquired a new position in shares of UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its position in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. National Bank of Canada FI grew its position in shares of UnitedHealth Group by 137.8% in the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after purchasing an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after buying an additional 847,054 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on UNH shares. Sanford C. Bernstein increased their price target on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday. Robert W. Baird reissued an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Royal Bank Of Canada reduced their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Trading Down 3.6%

NYSE UNH opened at $354.30 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47. The business’s fifty day moving average is $318.21 and its 200 day moving average is $350.41.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business earned $6.80 EPS. The company’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.